NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2020-06-28 120c9b2em65(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0
经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept#心血管#

1127 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2022-09-14 ms3000001002916195

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：代谢;营养;心血管
经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。

52 0

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-09-22 ms8000001931272154

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：心血管药物
经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了

299 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

引言中文章的创新性如何体现？

209 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

引言需要写什么内容？

199 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2020-01-04 Dr_WangBH

投稿3个多月了一直就是under review，效率真的低

385 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2019-11-16 努力的科研小白

接收综述吗？

377 0

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2015-08-06 wgwang2003092

under review 41 天，出现了reviewer declined，悲催啊。还要等多久？

610 0

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2015-07-28 wgwang2003092

审稿速度:2.0
经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？

580 0

[GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248833, encodeId=b313124883313, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：代谢;营养;心血管 经验分享：这个杂志有点坑人，审稿周期很慢，需要自己推荐审稿人，投稿过程还挺繁琐的。耗了三个月的时间，最后拒稿了，比较磨人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7a05609949, createdName=ms3000001002916195, createdTime=Wed Sep 14 10:17:22 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579935, encodeId=33365e993505, content=接收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514281, encodeId=c7f451428114, content=under review 41 天，出现了reviewer declined，悲催啊。还要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Thu Aug 06 07:08:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513973, encodeId=8e8f5139e3aa, content=审稿速度:2.0 经验分享：投稿已经40天了，现在还是under review。不解的是Reviewer Invited两个，只有一个出现under review。然后complete and send review 状态已经2周多了，这个状态是什么意思？为什么会时间这么长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50151630174, createdName=wgwang2003092, createdTime=Tue Jul 28 17:37:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482466, encodeId=16be4824668c, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:20:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 neuron2010

偏重的研究方向：心血管;

590 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务